| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout
|
Chao, Jeannie
|
|
2009
|
11 |
2 |
p. 135-140
|
article
|
| 2 |
A sugar transporter regulates serum urate levels: Implications for prevention and management of hyperuricemia in gout
|
Terkeltaub, Robert A.
|
|
2009
|
11 |
2 |
p. 83-85
|
article
|
| 3 |
Calcifying tendinitis of the shoulder: Advances in imaging and management
|
Gosens, Taco
|
|
2009
|
11 |
2 |
p. 129-134
|
article
|
| 4 |
Counterpoint: Hydroxyapatite crystal deposition is not intimately involved in the pathogenesis and progression of human osteoarthritis
|
Pritzker, Kenneth P. H.
|
|
2009
|
11 |
2 |
p. 148-153
|
article
|
| 5 |
Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials
|
Au, Karen
|
|
2009
|
11 |
2 |
p. 111-119
|
article
|
| 6 |
Current developments in pediatric systemic sclerosis
|
Foeldvari, Ivan
|
|
2009
|
11 |
2 |
p. 97-102
|
article
|
| 7 |
Genetics of systemic sclerosis-associated pulmonary arterial hypertension: Recent progress and current concepts
|
Shah, Sanjiv J.
|
|
2009
|
11 |
2 |
p. 89-96
|
article
|
| 8 |
Is scleroderma a vasculopathy?
|
Fleming, Jo Nadine
|
|
2009
|
11 |
2 |
p. 103-110
|
article
|
| 9 |
Point: Hydroxyapatite crystal deposition is intimately involved in the pathogenesis and progression of human osteoarthritis
|
McCarthy, Geraldine M.
|
|
2009
|
11 |
2 |
p. 141-147
|
article
|
| 10 |
Quality of life and quality of care for patients with gout
|
Singh, Jasvinder A.
|
|
2009
|
11 |
2 |
p. 154-160
|
article
|
| 11 |
Tissue stiffness, latent TGF-β1 Activation, and mechanical signal transduction: Implications for the pathogenesis and treatment of fibrosis
|
Hinz, Boris
|
|
2009
|
11 |
2 |
p. 120-126
|
article
|
Journal description